2-80302369-G-C

Variant summary

Our verdict is Uncertain significance. The variant received 2 ACMG points: 2P and 0B. PM2

The NM_178839.5(LRRTM1):​c.1451C>G​(p.Ser484Cys) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000684 in 1,461,890 control chromosomes in the GnomAD database, with no homozygous occurrence. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.8e-7 ( 0 hom. )

Consequence

LRRTM1
NM_178839.5 missense

Scores

2
5
12

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 8.19

Publications

0 publications found
Variant links:
Genes affected
LRRTM1 (HGNC:19408): (leucine rich repeat transmembrane neuronal 1) Predicted to be involved in regulation of postsynaptic density assembly and regulation of presynapse assembly. Predicted to act upstream of or within several processes, including long-term synaptic potentiation; negative regulation of receptor internalization; and positive regulation of synapse assembly. Located in endoplasmic reticulum and growth cone. Is active in GABA-ergic synapse. Is integral component of postsynaptic specialization membrane. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA2 (HGNC:2510): (catenin alpha 2) Enables actin filament binding activity. Involved in negative regulation of Arp2/3 complex-mediated actin nucleation; regulation of neuron migration; and regulation of neuron projection development. Located in cytoplasm. Implicated in complex cortical dysplasia with other brain malformations. [provided by Alliance of Genome Resources, Apr 2022]
CTNNA2 Gene-Disease associations (from GenCC):
  • cortical dysplasia, complex, with other brain malformations 9
    Inheritance: AR Classification: STRONG, MODERATE Submitted by: PanelApp Australia, Ambry Genetics, Labcorp Genetics (formerly Invitae), G2P

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 2 ACMG points.

PM2
Very rare variant in population databases, with high coverage;

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
LRRTM1NM_178839.5 linkc.1451C>G p.Ser484Cys missense_variant Exon 2 of 2 ENST00000295057.4 NP_849161.2 Q86UE6
CTNNA2NM_001282597.3 linkc.1057-90842G>C intron_variant Intron 7 of 18 ENST00000402739.9 NP_001269526.1 P26232-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
LRRTM1ENST00000295057.4 linkc.1451C>G p.Ser484Cys missense_variant Exon 2 of 2 1 NM_178839.5 ENSP00000295057.3 Q86UE6
CTNNA2ENST00000402739.9 linkc.1057-90842G>C intron_variant Intron 7 of 18 1 NM_001282597.3 ENSP00000384638.4 P26232-1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.84e-7
AC:
1
AN:
1461890
Hom.:
0
Cov.:
30
AF XY:
0.00000138
AC XY:
1
AN XY:
727246
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
33480
American (AMR)
AF:
0.00
AC:
0
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.00
AC:
0
AN:
86256
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
8.99e-7
AC:
1
AN:
1112010
Other (OTH)
AF:
0.00
AC:
0
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Apr 04, 2025
Ambry Genetics
Significance:Uncertain significance
Review Status:criteria provided, single submitter
Collection Method:clinical testing

The c.1451C>G (p.S484C) alteration is located in exon 2 (coding exon 1) of the LRRTM1 gene. This alteration results from a C to G substitution at nucleotide position 1451, causing the serine (S) at amino acid position 484 to be replaced by a cysteine (C). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.23
BayesDel_addAF
Benign
0.00051
T
BayesDel_noAF
Benign
-0.24
CADD
Pathogenic
32
DANN
Uncertain
0.98
DEOGEN2
Benign
0.17
T;T
Eigen
Uncertain
0.67
Eigen_PC
Pathogenic
0.68
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.88
.;D
M_CAP
Benign
0.025
D
MetaRNN
Uncertain
0.63
D;D
MetaSVM
Benign
-0.85
T
MutationAssessor
Benign
1.4
L;L
PhyloP100
8.2
PrimateAI
Pathogenic
0.85
D
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.21
Sift
Benign
0.048
D;D
Sift4G
Benign
0.092
T;T
Polyphen
1.0
D;D
Vest4
0.67
MutPred
0.52
Loss of disorder (P = 0.0125);Loss of disorder (P = 0.0125);
MVP
0.15
ClinPred
0.97
D
GERP RS
5.2
Varity_R
0.32
gMVP
0.84
Mutation Taster
=56/44
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr2-80529494; API